Skip to main content

Human Gene Therapy

  • Chapter
The ABCs of Gene Cloning
  • 2924 Accesses

Abstract

There are more than 4,000 known inherited disorders. The majority of them have minimal effects, but a few causes physical and mental abnormalities that may be life threatening. Genetic diseases that are candidates for gene therapies include severe combined immunodeficiency, thalassaemia, and cystic fibrosis. Since these genetic diseases are each caused by a single defective gene, one potential treatment is to introduce a normal functional copy of the appropriate gene into the cell tissue that is affected. In effect, the normal (therapeutic) gene augments the defective gene in the patient. Gene therapy is not restricted to only treating genetic disorders. The general technology of transferring genetic materials into a patient is also applied to diseases such as cancer, AIDS, and cardiovascular diseases. Many of the approved clinical trials on gene therapy are for the treatment of diseases other than genetic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Chapter 18: Human Gene Therapy

  • Blaese, R. M. 1997. Gene therapy for cancer. Sci. Am. 276, 111–120.

    Article  PubMed  CAS  Google Scholar 

  • Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshew, P., Greenblatt, J. L., Rosenberg, S. A., Klein, H. Berger, M., Mullen, C. A., Ramsey, J., Muul, L., Morgan, R. A., and Anderson, W. F. 1995. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475–480.

    Article  PubMed  CAS  Google Scholar 

  • Felgner, P. L. 1997. Nonviral strategies for gene therapy. Sci. Am. 276(6), 102–106.

    PubMed  CAS  Google Scholar 

  • Hock, R. A., Miller, D., and Osborne, W. R. A. 1989. Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74, 876–881.

    PubMed  CAS  Google Scholar 

  • Lundstrom, K. 2003. Latest development in viral vectors for gene therapy. Trends Biotechnol. 21, 117–122.

    Article  PubMed  CAS  Google Scholar 

  • Morgan, R. A., and Anderson, W. F. 1993. Human gene therapy. Ann. Rev. Biochem. 62, 191–217.

    Article  PubMed  CAS  Google Scholar 

  • Mountain, A. 2000. Gene therapy: the first decade. Trends Biotechnol. 18, 119–128.

    Article  PubMed  CAS  Google Scholar 

  • Sheikh, N. A., and Morrow, W. J. W. 2003. Guns, genes, and spleen: a coming of age for rational vaccine design. Methods 31, 183–192.

    Article  PubMed  CAS  Google Scholar 

  • Verma, I. M. 1990. Gene therapy. Sci. Am. 263(5), 68–84.

    Article  PubMed  CAS  Google Scholar 

  • Weiner, D. B., and Kennedy, R. C. 1999. Genetic vaccines. Sci. Am. 281(1), 50–57.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Human Gene Therapy. In: The ABCs of Gene Cloning. Springer, Boston, MA. https://doi.org/10.1007/0-387-28679-9_18

Download citation

Publish with us

Policies and ethics